Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marwan Sabbagh

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Current Alzheimer Research|September 23, 2015
Clinical Assessment of Cognitive Decline in Adults with Down SyndromeMarwan Sabbagh, Jamie Edgin
Current Alzheimer Research|February 28, 2017
Editorial: Current and Emerging Therapeutics in ADMarwan Sabbagh, Boris Decourt
Neurology and Therapy|February 1, 2019
Neurology and Therapy: Looking Back on 2018 and Forward to 2019Marwan Sabbagh, Antonio Bertolotto
BMC Neurology|February 9, 2011
Progressive cholinergic decline in Alzheimer's Disease: consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatologyMarwan Sabbagh, Jeffrey Cummings
International Journal of Alzheimer'S Disease|December 23, 2011
Broader considerations of higher doses of donepezil in the treatment of mild, moderate, and severe Alzheimer's diseaseCamryn Berk, Marwan Sabbagh
Expert Opinion on Investigational Drugs|August 21, 2015
Early investigational drugs targeting tau protein for the treatment of Alzheimer's diseaseKeshav Anand, Marwan Sabbagh
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 31, 2016
Amyloid Imaging: Poised for Integration into Medical PracticeKeshav Anand, Marwan Sabbagh
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 20, 2010
Commentary on "Developing a national strategy to prevent dementia: Leon Thal Symposium 2009." Creating a national database for successful agingAra S Khachaturian, Marwan Sabbagh
The New England Journal of Medicine|January 4, 2023
Response to: Multiple Cerebral Hemorrhages in a Patient Receiving Lecanemab and Treated with t-PA for StrokeMarwan Sabbagh, Christopher H van Dyck
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 11, 2019
The path forward in Alzheimer's disease therapeutics: Reevaluating the amyloid cascade hypothesisMartin Tolar, Susan Abushakra, Marwan Sabbagh
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Current Alzheimer Research|September 23, 2015
Clinical Assessment of Cognitive Decline in Adults with Down SyndromeMarwan Sabbagh, Jamie Edgin
Current Alzheimer Research|February 28, 2017
Editorial: Current and Emerging Therapeutics in ADMarwan Sabbagh, Boris Decourt
Neurology and Therapy|February 1, 2019
Neurology and Therapy: Looking Back on 2018 and Forward to 2019Marwan Sabbagh, Antonio Bertolotto
BMC Neurology|February 9, 2011
Progressive cholinergic decline in Alzheimer's Disease: consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatologyMarwan Sabbagh, Jeffrey Cummings
International Journal of Alzheimer'S Disease|December 23, 2011
Broader considerations of higher doses of donepezil in the treatment of mild, moderate, and severe Alzheimer's diseaseCamryn Berk, Marwan Sabbagh
Expert Opinion on Investigational Drugs|August 21, 2015
Early investigational drugs targeting tau protein for the treatment of Alzheimer's diseaseKeshav Anand, Marwan Sabbagh
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 31, 2016
Amyloid Imaging: Poised for Integration into Medical PracticeKeshav Anand, Marwan Sabbagh
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 20, 2010
Commentary on "Developing a national strategy to prevent dementia: Leon Thal Symposium 2009." Creating a national database for successful agingAra S Khachaturian, Marwan Sabbagh
The New England Journal of Medicine|January 4, 2023
Response to: Multiple Cerebral Hemorrhages in a Patient Receiving Lecanemab and Treated with t-PA for StrokeMarwan Sabbagh, Christopher H van Dyck
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 11, 2019
The path forward in Alzheimer's disease therapeutics: Reevaluating the amyloid cascade hypothesisMartin Tolar, Susan Abushakra, Marwan Sabbagh
Pageof 10